You have no items in your shopping cart.
On Promotion 
Tested Applications
Reactivity
Predicted Reactivity
Conjugation
Unconjugated 733FITC 79PE 62APC 53Biotin 34PE/Cy5 22PerCP 21PerCP/Cy5.5 21HRP 18PE/Cy7 17APC/Cy7 15Cy3 9PE/Cy5.5 9APC/Cy5.5 7Cy5 7Pacific Blue 7AP 5BF405 5BF488 5BF647 5IRDye800 5RPE 5BF555 4BF594 4BF700 4Cy5.5 4Cy7 4FITC/RPE 4Fluoro488 4Fluoro550 4Fluoro594 4Fluoro647 4PerCP/Cy7 4violetFluor 450 4BF350 3BF680 3BF750 3Elab Fluor Red 780 3FITC/PE 3PE/Texas Red 3RBITC 3redFluor 710 3violetFluor 500 3BioWave Violet 450 2Elab Fluor Violet 450 2FITC/PE/Cy5.5 1PerCP/Cy5 1SureLight 488 1mFV450 1
Featured Product
Biotinylated Human CD3E [orb2993856]Biotin
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 40.5 KDa. Observed: 45-60 KDa, reducing conditions
20 μg, 100 μg- Recombinant Human CD3D&CD3E Heterodimer (C-6His) [orb2993864]
Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 10.6&12.8 KDa. Observed: 16-30 KDa, reducing conditions
10 μg, 50 μg, 1 mg, 500 μg - Human CD3E [orb2994304]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 38.7 KDa. Observed: 40-50 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Cynomolgus CD3d [orb2994176]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 10.4 KDa. Observed: 20-35 KDa, reducing conditions
500 μg, 1 mg, 10 μg, 50 μg - Cynomolgus CD3E [orb2994067]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 38 KDa. Observed: 38-55 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Human CD3E [orb2993920]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 28.5 KDa. Observed: 32-40 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Cynomolgus CD3D&CD3E Heterodimer [orb2993714]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 37&38.3 KDa. Observed: 40-60 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Human CD3E&CD3G Heterodimer [orb2993735]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 39.2&38.1 KDa. Observed: 40-60 KDa, reducing conditions
1 mg, 10 μg, 50 μg, 500 μg - Cynomolgus CD3d [orb2994733]
Unconjugated
SDS-PAGE: Greater than 90% as determined by reducing SDS-PAGE.
Predicted: 36.7 KDa. Observed: 50-65 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Human CD3D&CD3E Heterodimer V2 [orb2992888]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE. (QC verified)
Predicted: 14.6&16.0 KDa. Observed: 20&(22-38) KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg